Equillium, INC. (EQ) — 8-K Filings

8-K Filings (21)

• Equillium, Inc. Files 8-K on Corporate Changes — Oct 6, 2025 Risk: medium
  Equillium, Inc. filed an 8-K on October 6, 2025, reporting changes related to its certifying accountant, departure/election of directors, appointment of officer
• Equillium, Inc. Files 8-K Report — Sep 19, 2025 Risk: low
  On September 19, 2025, Equillium, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating upd
• Equillium, Inc. Files 8-K Under 'Other Events' — Sep 4, 2025 Risk: low
  Equillium, Inc. filed an 8-K on September 4, 2025, reporting an event that occurred on August 29, 2025. The filing is categorized under 'Other Events' and does
• Equillium, Inc. Files 8-K on Agreements and Equity Sales — Aug 11, 2025 Risk: medium
  Equillium, Inc. filed an 8-K on August 11, 2025, reporting on an entry into a material definitive agreement, unregistered sales of equity securities, and Regula
• Equillium, Inc. Files 8-K on Material Agreements and Financials — Aug 4, 2025 Risk: medium
  Equillium, Inc. filed an 8-K on August 4, 2025, reporting on an entry into a material definitive agreement, results of operations, and other events. The filing
• Equillium Faces Listing Rule Concerns — Jun 13, 2025 Risk: high
  Equillium, Inc. filed an 8-K on June 13, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The filing indicates
• Equillium, Inc. Files 8-K on Officer/Director Changes & More — May 22, 2025 Risk: medium
  Equillium, Inc. filed an 8-K on May 22, 2025, reporting on events from May 21, 2025. The filing covers the departure of directors or certain officers, the elect
• Equillium, Inc. Files 8-K on Financials — Apr 24, 2025 Risk: low
  On April 24, 2025, Equillium, Inc. filed an 8-K report. The filing pertains to the company's results of operations and financial condition, as well as financial
• Equillium, Inc. Files 8-K: Other Events — Feb 6, 2025 Risk: medium
  Equillium, Inc. filed an 8-K on February 6, 2025, reporting "Other Events." The filing does not contain specific details about the nature of these events, dolla
• Equillium Faces NASDAQ Delisting Concerns — Dec 13, 2024 Risk: high
  Equillium, Inc. filed an 8-K on December 13, 2024, to report a notice of delisting or failure to satisfy a continued listing rule or standard. The company is fa
• Equillium, Inc. Reports Board and Officer Changes — Dec 12, 2024 Risk: medium
  Equillium, Inc. filed an 8-K on December 12, 2024, reporting changes related to its board of directors and officers, as well as compensatory arrangements. The f
• Equillium Appoints New Chief Medical Officer — Oct 31, 2024 Risk: medium
  On October 30, 2024, Equillium, Inc. announced the appointment of Dr. Tiffany L. Rose as Chief Medical Officer. Dr. Rose brings extensive experience in clinical
• Equillium Faces NASDAQ Listing Concerns — Jul 23, 2024 Risk: high
  Equillium, Inc. filed an 8-K on July 23, 2024, to report a notice of delisting or failure to satisfy a continued listing rule or standard. The company's common
• Equillium, Inc. Files 8-K on Financial Condition — Jul 18, 2024 Risk: low
  Equillium, Inc. filed an 8-K on July 18, 2024, to report on its results of operations and financial condition. The filing provides an update on the company's st
• Equillium, Inc. Files 8-K for Other Events — Jun 4, 2024 Risk: low
  Equillium, Inc. filed an 8-K on June 4, 2024, to report other events and financial statements. The company, incorporated in Delaware, is based in La Jolla, Cali
• Equillium, Inc. Files 8-K on Security Holder Vote Matters — May 23, 2024 Risk: low
  Equillium, Inc. filed an 8-K on May 23, 2024, reporting on a submission of matters to a vote of security holders. The filing date for the report is May 22, 2024
• Equillium, Inc. Files 8-K — Apr 1, 2024 Risk: low
  Equillium, Inc. filed an 8-K on April 1, 2024, to report other events. The filing does not contain specific details about the nature of these events, dollar amo
• Equillium, Inc. Files 8-K on Financials — Mar 25, 2024 Risk: low
  On March 25, 2024, Equillium, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as fi
• Equillium Appoints New CMO, Adds Director, Renews CEO Contract — Mar 8, 2024 Risk: medium
  Equillium, Inc. announced on March 6, 2024, a series of executive and board changes. Dr. Daniel J. O'Connell has been appointed as the new Chief Medical Officer
• Equillium Files 8-K on Financial Condition and Other Events — Feb 23, 2024 Risk: low
  Equillium, Inc. filed an 8-K on February 23, 2024, reporting on its financial condition and other events. The filing indicates the company's business address as
• Equillium Files 8-K for 'Other Event' on Feb 21 — Feb 22, 2024 Risk: low
  Equillium, Inc. filed an 8-K on February 22, 2024, reporting an 'Other Event' that occurred on February 21, 2024. The filing indicates a current report pursuant

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX